ReviewFrontiers in medicine2026
Research progress on the application of dual energy CT in gastric diseases.
Review in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and Objective: Early detection and precise preoperative staging of benign and malignant gastric tumors are crucial for tailoring personalized treatment strategies and improving patient prognosis. Dual-energy CT (DECT), through material decomposition techniques, provides multiparametric quantitative information. This enables a transition in gastric imaging from a single morphological assessment to a comprehensive "morphological and functional" evaluation. This review aims to systematically elaborate on the latest advances in the clinical application of DECT for gastric tumor evaluation and other gastric diseases. Main content: This article reviews recent literature, focusing on the progress of DECT in the diagnosis and treatment of gastric tumors, as well as clinical studies based on quantitative DECT parameters. Key areas covered include the improvement of early detection rates, differentiation of benign and malignant lesions, precise preoperative staging, and therapeutic response assessment. Conclusion: Dual-energy CT provides rich, multidimensional quantitative metrics for the comprehensive evaluation of gastric tumors, significantly enhancing diagnostic performance and precision. With hardware upgrades and deep integration with artificial intelligence technologies such as deep learning, DECT is poised to play a more central role in the precision medicine and longitudinal management of gastric cancer.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.